Laurence Reid - 23 Nov 2024 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Director
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol
KALV
Transactions as of
23 Nov 2024
Net transactions value
$0
Form type
3
Filing time
26 Nov 2024, 16:39:28 UTC
Previous filing
25 Sep 2023
Next filing
15 Aug 2025

No securities are beneficially owned.